Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2000;36:376-382

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whalen, E. J.
Right arrow Articles by Lewis, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whalen, E. J.
Right arrow Articles by Lewis, S. J.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Animal models of human disease
Right arrow Hypertension - basic studies
Right arrow Receptor pharmacology
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2000;36:376.)
© 2000 American Heart Association, Inc.


Scientific Contributions

ß-Adrenoceptor Dysfunction After Inhibition of NO Synthesis

Erin J. Whalen; Alan Kim Johnson; Stephen J. Lewis

From the Departments of Pharmacology (E.J.W., A.K.J., S.J.L.) and Psychology (A.K.J.) and The Cardiovascular Center (E.J.W., A.K.J.), University of Iowa, Iowa City.

Correspondence to Stephen J. Lewis, PhD, Department of Pharmacology, University of Iowa, Iowa City, IA 52242. E-mail stephen-lewis{at}uiowa.edu

Abstract—Gs protein–coupled ß-adrenoceptors rapidly desensitize on exposure to agonists in reconstituted membrane preparations, whereas rapid tachyphylaxis to ß-adrenoceptor–mediated vasodilation does not readily occur in vivo. This study examined the possibility that endothelium-derived nitrosyl factors prevent the rapid desensitization of ß-adrenoceptors in the vascular smooth muscle of resistance arteries in pentobarbital-anesthetized rats. The fall in mean arterial blood pressure and in hindquarter vascular resistance produced by the ß-adrenoceptor agonist isoproterenol (ISO, 0.1 to 10 µg/kg IV) was slightly but significantly smaller in rats treated with the NO synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME, 100 µmol/kg IV) than in saline-treated rats. The ISO-induced fall in mesenteric resistance was similar in L-NAME–treated and in saline-treated rats. The fall in hindquarter vascular resistance and in mesenteric resistance produced by ISO (8x10 µg/kg IV) was subject to tachyphylaxis on repeated injection in rats treated with L-NAME (100 µmol/kg IV) but not in rats treated with saline. Injections of L-S-nitrosocysteine (1200 nmol/kg IV), a lipophobic S-nitrosothiol, before each injection of ISO (10 µg/kg IV) prevented tachyphylaxis to ISO in L-NAME–treated rats. The vasodilator effects of ISO (0.1 to 10 µg/kg IV) in L-NAME–treated rats that received 8 injections of ISO (10 µg/kg IV) were markedly smaller than in L-NAME–treated rats that received 8 injections of saline. These results indicate that (1) the vasodilator actions of ISO in pentobarbital-anesthetized rats only minimally involve the release of endothelium-derived nitrosyl factors, (2) the effects of ISO are subject to development of tachyphylaxis in L-NAME–treated rats, and (3) tachyphylaxis to ISO is prevented by L-S-nitrosocysteine. These findings suggest that endothelium-derived nitrosyl factors may prevent desensitization of ß-adrenoceptors in vivo.


Key Words: adrenergic receptor agonists • hemodynamics • nitric oxide • rats




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. F. Figueroa, I. Poblete, R. Fernandez, C. Pedemonte, V. Cortes, and J. P. Huidobro-Toro
NO production and eNOS phosphorylation induced by epinephrine through the activation of {beta}-adrenoceptors
Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H134 - H143.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Jacob, E. M. Garland, F. Costa, C. M. Stein, H.-G. Xie, R. M. Robertson, I. Biaggioni, and D. Robertson
{beta}2-Adrenoceptor Genotype and Function Affect Hemodynamic Profile Heterogeneity in Postural Tachycardia Syndrome
Hypertension, March 1, 2006; 47(3): 421 - 427.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Nozik-Grayck, E. J. Whalen, J. S. Stamler, T. J. McMahon, P. Chitano, and C. A. Piantadosi
S-nitrosoglutathione inhibits {alpha}1-adrenergic receptor-mediated vasoconstriction and ligand binding in pulmonary artery
Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L136 - L143.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
L. G. Que, L. Liu, Y. Yan, G. S. Whitehead, S. H. Gavett, D. A. Schwartz, and J. S. Stamler
Protection from Experimental Asthma by an Endogenous Bronchodilator
Science, June 10, 2005; 308(5728): 1618 - 1621.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Nozik-Grayck, T. J. McMahon, Y.-C. T. Huang, C. S. Dieterle, J. S. Stamler, and C. A. Piantadosi
Pulmonary vasoconstriction by serotonin is inhibited by S-nitrosoglutathione
Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L1057 - L1065.
[Abstract] [Full Text] [PDF]